Post-Trauma Migraine Botox Criteria Explained
After a rear-end collision on El Paso’s Loop 375, a 38-year-old warehouse supervisor noticed a dull ache at the base of her skull by the next morning. Within a week, the pain pulsed behind one eye. In addition, light hurt, and ordinary sounds became sharp. She missed three workdays in the first month. By month four, she counted eighteen headache days, ten of which had migraine features. Her headache diary, cervical range-of-motion measurements, and dual-scope clinical notes now form the timeline that both explains how the crash produced this pattern. These records also support guideline-based preventive care with onabotulinumtoxinA (Botox).
Rapid deceleration loads the cervical spine. Facet joints, upper cervical ligaments, and deep neck muscles stretch beyond normal limits. Sensory signals from these tissues converge with the trigeminal system in the upper cervical spinal cord. The result is heightened sensitivity that can turn occasional neck-related pain into a recurring migraine-like cycle. In these cases, post-traumatic headache is recognized when symptoms begin within seven days of injury or recovery of consciousness (Headache Classification Committee of the International Headache Society, 2018). When the pattern continues beyond three months and reaches fifteen or more headache days per month, with migraine features on at least eight of those days, the clinical picture meets the International Classification of Headache Disorders, Third Edition criteria for chronic migraine.
In personal-injury practice, the same records serve two purposes. They show the temporal link between the collision mechanics and the new or aggravated headache pattern. This finding supports medical causation under Texas law. They also document the frequency and characteristics required for FDA-approved Botox prophylaxis in adults with chronic migraine (at least fifteen headache days per month lasting four hours or longer). Defense arguments that the headaches were “already present” or “subjective” weaken when a dated diary, serial examinations, and co-signed notes from a dual-licensed clinician and medical director establish the change after the crash.
A usable record begins with the pre-collision baseline. Did the patient have occasional tension headaches or a diagnosed migraine disorder? How many days per month? What medications were used? After the crash, the clinician records the exact date of first headache, associated neck symptoms, and functional limits. Weekly or monthly diary entries capture:
Digital range-of-motion measurements and soft-tissue findings at each visit show whether cervical restriction tracks with headache frequency. When the dual-licensed provider (Doctor of Chiropractic and board-certified Family Nurse Practitioner) documents both the musculoskeletal drivers and the neurological features, and the medical director reviews the overall medical picture, the file resists the common “no objective findings” claim. For more detail, related guidance on establishing medical-legal causation appears at https://dralexjimenez.com.
Chronic migraine under ICHD-3 requires headache on fifteen or more days per month for more than three months, with migraine characteristics on at least eight days, in a person who previously met the criteria for episodic migraine and is not better explained by another diagnosis. The Botox label uses a closely related threshold: adults with fifteen or more headache days per month in which the headache lasts four hours or longer. The pivotal PREEMPT trials demonstrated that 155 units injected at 31 sites every twelve weeks reduced headache days more than placebo (Dodick et al., 2010). In the post-trauma setting, the same criteria apply once the diary and clinical course confirm the frequency threshold has been crossed. In addition, secondary causes (medication-overuse headache, pure cervicogenic headache, and untreated sleep apnea) must be addressed.
These records strengthen proof of causation in car accident cases while guiding approved care at https://dralexjimenez.com. When the timeline shows the jump from two or three headache days per month before the crash to eighteen afterward, the Eggshell Plaintiff rule protects recovery for the aggravation even if a mild pre-existing susceptibility existed. Meanwhile, the same data support medical necessity for Botox as preventive therapy that can reduce reliance on daily analgesics.
Beneficence is served when evidence-based prevention is offered once the frequency criteria are met. Reducing headache days restores work capacity, sleep, and daily function rather than merely masking pain with acute medication.
Non-maleficence is advanced by favoring a drug-free or drug-sparing pathway. Chiropractic care, neurofunctional acupuncture, and electroacupuncture address the cervical drivers while Botox targets the central sensitization that keeps the migraine pattern active. This combination lowers the risk of medication-overuse headache and reduces long-term analgesic exposure.
Autonomy is protected when the patient and counsel receive the same dated diary, examination findings, and treatment rationale. Shared records help the patient understand why Botox is being considered. These records also allow the attorney to evaluate causation and future medical costs without surprise.
Injury Medical Clinic PA is the only integrated clinic in El Paso that combines a medical director with a nurse practitioner specializing in soft-tissue injury. Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine, provides medical direction, risk stratification, and oversight of complex metabolic or comorbid conditions. Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, dual-licensed as a Doctor of Chiropractic and board-certified Family Nurse Practitioner, evaluates and treats the cervical soft-tissue and neurological components of post-trauma headache while coordinating with Dr. Cardenas. This dual-scope, co-signed documentation allows the same clinical notes to support both courtroom causation opinions and guideline-based preventive care decisions. For further detail, integrated migraine management after injury is available at https://dralexjimenez.com.
Patients and attorneys who need a clear, chronological record of how a collision produced a chronic migraine pattern that meets established Botox criteria can schedule a comprehensive evaluation. The resulting file links the mechanism, timeline, and objective findings, allowing medically necessary preventive care to proceed while keeping the legal causation foundation intact.
Headache Classification Committee of the International Headache Society (IHS). (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38(1), 1–211. https://doi.org/10.1177/0333102417738202
Dodick, D. W., Turkel, C. C., DeGryse, R. E., Aurora, S. K., Silberstein, S. D., Lipton, R. B., Diener, H. C., & Brin, M. F. (2010). OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache, 50(6), 921–936. https://doi.org/10.1111/j.1526-4610.2010.01678.x
AbbVie. (2024). BOTOX (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use [Prescribing information]. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103000s5322lbl.pdf